VEGFA and Anxiety: Our study found that those who were responding favorably to other anti-VEGF intravitreal drugs, when injected during the window effect of previous therapies, continued to retrieve positive functional and anatomical outcomes after one injection of brolucizumab, with the additional potential benefit for a lower treatment burden through less frequent hospital visits and anxiety-associated procedures.